Essential ingredients for rational drug design.


Journal

Bioorganic & medicinal chemistry letters
ISSN: 1464-3405
Titre abrégé: Bioorg Med Chem Lett
Pays: England
ID NLM: 9107377

Informations de publication

Date de publication:
15 10 2019
Historique:
received: 28 06 2019
revised: 03 09 2019
accepted: 04 09 2019
pubmed: 16 9 2019
medline: 23 10 2020
entrez: 16 9 2019
Statut: ppublish

Résumé

This short review focuses on three aspects of rational drug design that we consider of utmost importance: the conformation of small molecules in solid form, the conformation of small molecules in solution and lesser studied interactions in protein-ligand complexes. Using examples from recent literature, we will illustrate these different aspects and how they have contributed to the discovery of potent modulators.

Identifiants

pubmed: 31521476
pii: S0960-894X(19)30624-9
doi: 10.1016/j.bmcl.2019.126674
pii:
doi:

Substances chimiques

Enzyme Inhibitors 0
Heterocyclic Compounds 0
Ligands 0
Cyclin-Dependent Kinases EC 2.7.11.22

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

126674

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Ashley Jarvis (A)

Evotec (U.K.) Ltd., 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, United Kingdom.

Gilles Ouvry (G)

Evotec (U.K.) Ltd., 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, United Kingdom. Electronic address: gilles.ouvry@evotec.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH